(Q28567764)

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

The effect of insulin infusion and food intake on muscle protein synthesis in postabsorptive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Availability of eIF4E regulates skeletal muscle protein synthesis during recovery from exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

PHAS/4E-BPs as regulators of mRNA translation and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Bidirectional modulation of insulin action by amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Intracellular calcium: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Hormonal regulation of human muscle protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Effects of insulin-like growth factor-I (IGF-I), insulin and combined IGF-I-insulin infusions on protein metabolism in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Amino acid availability regulates p70 S6 kinase and multiple translation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301

Modulation of translation initiation in rat skeletal muscle and liver in response to food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.2000.279.2.E301